Listing Details
CARMELINA Clinical Trials
CARMELINA® is a long-term cardiovascular outcomes trial (CVOT) testing the impact of treatment with linagliptin versus placebo, on top of standard of care, on cardiovascular (CV) as well as kidney safety.
CARMELINA® is a long-term cardiovascular outcomes trial (CVOT) testing the impact of treatment with linagliptin versus placebo, on top of standard of care, on cardiovascular (CV) as well as kidney safety.